{
  "main_header": {
    "sid": 10039537,
    "name": "Amwill Health",
    "stock_name": "Amwill Health",
    "full_name": "Amwill Health Care Ltd",
    "name_url": "stocks-analysis/amwill-health",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "45.19",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "45.19",
    "mcapval": "88.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544353,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0U2L01017",
    "curr_date": "Jun 17",
    "curr_time": "",
    "bse_nse_vol": 18000,
    "exc_status": "Active",
    "traded_date": "Jun 17, 2026",
    "traded_date_str": "2026 06 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/amwill-health-10039537-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 174,
    "sid": "10039537",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/amwill-health-care-10039537"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Meeting Of The Board Of Directors Held On May 30 2026.",
      "datetime": "30-May-2026",
      "details": "Outcome of the meeting of the Board of Directors held on May 30 2026: Approval of Audited Financial Results for Half Year & FY 2026; recommendation of dividend @ 5% i.e.; Rs.0.50- per equity share of face value of Rs.10/- each.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Dividend Updates",
      "datetime": "30-May-2026",
      "details": "Recommendation of final dividend @ 5% i.e Rs. 0.50 per equity share face value of Rs. 10 each.",
      "source": "BSE"
    },
    {
      "caption": "SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO)",
      "datetime": "30-May-2026",
      "details": "Pursuant to regulation 32 of Sebi (LODR) Regulations 2015 we here by confirm that there is no deviation or variation in utilisation of proceeds of the IPO fund from the object stated in prospectus filed on February 10 2025. A statement of the same is attched herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News